Shree Ganesh Remedies (NSE:SGRL) Cyclically Adjusted PS Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SGRL Shree Ganesh Remedies Ltd NSE:SGRL
71 GF Score
Price ₹501.05
GF Value ₹589.26
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shree Ganesh Remedies Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shree Ganesh Remedies  (NSE:SGRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shree Ganesh Remedies Cyclically Adjusted PS Ratio Related Terms


Shree Ganesh Remedies Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Shree Ganesh Remedies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Ganesh Remedies Cyclically Adjusted PS Ratio Chart

Shree Ganesh Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.91 6.15 13.43 12.40 6.34

Shree Ganesh Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.40 0.00 0.00 0.00 6.34

NSE:SGRL vs : Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shree Ganesh Remedies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Ganesh Remedies Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shree Ganesh Remedies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Remedies's Cyclically Adjusted PS Ratio falls into.


NSE:SGRL
71GF Score
Shree Ganesh Remedies Ltd NSE:SGRL
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Ganesh Remedies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shree Ganesh Remedies's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar26 is calculated as:

For example, Shree Ganesh Remedies's adjusted Revenue per Share data for the fiscal year that ended in Mar26 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar26 (Change)*Current CPI (Mar26)
=85.1/330.2130*330.2130
=85.100

Current CPI (Mar26) = 330.2130.

Shree Ganesh Remedies Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201703 16.420 243.801 22.240
201803 26.503 249.554 35.069
201903 29.200 254.202 37.931
202003 48.314 258.115 61.809
202103 48.707 264.877 60.721
202203 58.950 287.504 67.707
202303 74.292 301.836 81.277
202403 99.183 312.332 104.861
202503 84.531 319.799 87.284
202603 85.100 330.213 85.100

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shree Ganesh Remedies (NSE:SGRL) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Remedies stock appears to be undervalued. The current stock price of ₹501.05 is trading 15% below its estimated GF Value™ of ₹589.26. GuruFocus considers Shree Ganesh Remedies to be Modestly Undervalued.

Key valuation signals for NSE:SGRL:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹589.26 vs. price of ₹501.05 (15% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the NSE:SGRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shree Ganesh Remedies Business Description

Comparable Companies
Other Exchanges 540737:India
Address Plot No. 6002, 6003, 6011 & 6012, GIDC Industrial Estate, Bharuch, Ankleshwar, GJ, IND, 393002
Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals, and specialty fine chemicals for the pharmaceutical industry. The company offers pharmaceutical and specialty chemical products, including Trityl chloride, Furoyl chloride, and Dinitolmide. The company's business falls under the primary segment of Bulk Drug Intermediaries.
71GF Score

Get the complete analysis for NSE:SGRL

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹501.05
Price
₹589.26
GF Value